BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Takwoingi Y, Botello AP, Burr JM, Azuara-Blanco A, Garway-Heath DF, Lemij HG, Sanders R, King AJ, Deeks JJ; Surveillance for Ocular Hypertension Study Group. External validation of the OHTS-EGPS model for predicting the 5-year risk of open-angle glaucoma in ocular hypertensives. Br J Ophthalmol 2014;98:309-14. [PMID: 24357494 DOI: 10.1136/bjophthalmol-2013-303622] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
Number Citing Articles
1 Pajouheshnia R, Groenwold RHH, Peelen LM, Reitsma JB, Moons KGM. When and how to use data from randomised trials to develop or validate prognostic models. BMJ 2019;365:l2154. [PMID: 31142454 DOI: 10.1136/bmj.l2154] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
2 Dixit A, Ashish A, Sharma R. A comparative study on efficacy of fixed combination timolol/brinzolamide versus travoprost monotherapy in drug-naïve open-angle glaucoma patients. Ther Adv Ophthalmol 2020;12:2515841420909666. [PMID: 32440640 DOI: 10.1177/2515841420909666] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Christopher M, Abràmoff MD, Tang L, Gordon MO, Kass MA, Budenz DL, Fingert JH, Scheetz TE. Stereo Photo Measured ONH Shape Predicts Development of POAG in Subjects With Ocular Hypertension. Invest Ophthalmol Vis Sci 2015;56:4470-9. [PMID: 26193923 DOI: 10.1167/iovs.14-16142] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
4 Salvetat ML, Zeppieri M, Tosoni C, Brusini P; Medscape. Baseline factors predicting the risk of conversion from ocular hypertension to primary open-angle glaucoma during a 10-year follow-up. Eye (Lond) 2016;30:784-95. [PMID: 27174381 DOI: 10.1038/eye.2016.86] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 1.8] [Reference Citation Analysis]
5 Hernández R, Burr J, Vale L, Azuara-blanco A, Cook J, Banister K, Tuulonen A, Ryan M. Monitoring ocular hypertension, how much and how often? A cost-effectiveness perspective. Br J Ophthalmol 2016;100:1263-8. [DOI: 10.1136/bjophthalmol-2015-306757] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
6 Sii S, Nasser A, Loo CY, Croghan C, Rotchford A, Agarwal PK. The impact of SIGN glaucoma guidelines on false-positive referrals from community optometrists in Central Scotland. Br J Ophthalmol 2019;103:369-73. [DOI: 10.1136/bjophthalmol-2017-311429] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]